Huh, G., Ryu, J. K., Chun, J. W., Kim, J. S., Park, N., Cho, I. R., . . . Kim, Y. (2020). High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin. BMC Cancer.

Huh, Gunn, Ji Kon Ryu, Jung Won Chun, Joo Seong Kim, Namyoung Park, In Rae Cho, Woo Hyun Paik, Sang Hyub Lee, and Yong-Tae Kim. "High Platelet-to-lymphocyte Ratio Is Associated With Poor Prognosis in Patients With Unresectable Intrahepatic Cholangiocarcinoma Receiving Gemcitabine Plus Cisplatin." BMC Cancer 2020.

Huh, Gunn, et al. "High Platelet-to-lymphocyte Ratio Is Associated With Poor Prognosis in Patients With Unresectable Intrahepatic Cholangiocarcinoma Receiving Gemcitabine Plus Cisplatin." BMC Cancer 2020.